Hillboro, Ore.
South San Francisco-based Genentech will construct a $250-million, 150,000-sf therapeutics filling and packaging facility on a 100-acre site in Hillsboro, Ore. The project will break ground in mid-2006 and reach completion by 2008; with U.S. FDA licensing, operations will commence by 2010. Genentech is also expanding its existing 427,000-sf Vacaville, Calif., manufacturing facility with the addition of 380,000 sf of production and fermentation space. The $800-million project broke ground in 2004; completion is slated for year-end 2007 with attainment of U.S. FDA licensing in 2009.
